|
Volumn 341, Issue , 2010, Pages
|
How small changes led to big profits for insulin manufacturers.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
DRUG DERIVATIVE;
INSULIN;
ARTICLE;
COMMERCIAL PHENOMENA;
DRUG INDUSTRY;
ECONOMICS;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
COMMERCE;
DIABETES MELLITUS, TYPE 2;
DRUG INDUSTRY;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
|
EID: 79251569624
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.c7139 Document Type: Article |
Times cited : (15)
|
References (0)
|